# Therapeutic Innovation in Type 2 DIABetes (IT-DIAB)

> **NCT01218061** · NA · UNKNOWN · sponsor: **Nantes University Hospital** · enrollment: 366 (actual)

## Conditions studied

- Pre-diabetes

## Interventions

- **OTHER:** Pre-diabetes screening

## Key facts

- **NCT ID:** NCT01218061
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-06
- **Primary completion:** 2023-06
- **Final completion:** 2023-06
- **Target enrollment:** 366 (ACTUAL)
- **Last updated:** 2017-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01218061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01218061, "Therapeutic Innovation in Type 2 DIABetes (IT-DIAB)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01218061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*